On November 21, the New York Department of Financial Services (DFS) announced sweeping market conduct regulations for pharmacy benefit managers (PBMs) serving health plans in the state. The DFS rule implements a landmark 2021 bill, S. 3762/A. 1396, which imposed restrictions on PBM contracts with health plans and pharmacies and established consumer protections. This action follows previous DFS rulemaking that created a broad definition of pharmacy benefit management services, required PBMs operating in the state to obtain a license, and established annual reporting requirements.

Missed our live information session about AMCP's Executive Fellowship for 2025-2026 or want to rewatch it? View the session below featuring past and current AMCP Executive Fellows as they share their unique experiences throughout their fellowship and highlight how the program helped them achieve their career goals as pharmacists.

View our Market Insights webinar to explore the latest practice recommendations in the management and treatment of food allergies.

In a world where innovative therapies are entering the market at an unprecedented pace, stakeholders need quick access to reliable information to help ensure the health care system is working as it should. They need fresh perspectives and data to keep up with how tools and techniques are working to help maintain balance in the managed care ecosystem. Enter AMCP’s recently released 2024 Access, Affordability, and Outcomes (AAO) report, which serves as a useful guide on how managed care pharmacy tools drive impact for patients.

More than 2,500 managed care pharmacy professionals from health plans, PBMs, pharmaceutical manufacturers, and other managed care organizations convened in Las Vegas, NV from Oct. 14–17 for AMCP Nexus 2024, the industry’s premier fall meeting. Attendees connected with like-minded professionals, discussed the key trends impacting their work, and expanded their perspectives through leading-edge education sessions.

Welcome to the latest update from Professional Affairs! This fall has been packed with major developments—from the release of Maximum Fair Prices for Medicare drugs to continued government focus of pharmacy benefit managers and much more.

View an executive summary of the key findings from the AMCP 2024 Access, Affordability and Outcomes: The Value of Managed Care Pharmacy report.